Elizabeth Corteselli used an NC TraCS pilot grant to create a new model for studying lung diseases and potential treatments. Only a few medications are currently approved to treat idiopathic pulmonary fibrosis (IPF) in the U.S., and these can sometimes cause significant side effects. Elizabeth Corteselli, a pediatric allergy and immunology researcher at the UNC School of Medicine, received help from NC TraCS to create a new lab model of the lung, giving researchers a way to observe how our lungs interact with everything we might breathe in, from pollution to dust to medications.

Read more

BRAINY-T1D is a nationwide effort aimed at understanding the earliest effects of Type 1 Diabetes in young children. UNC is one of eleven campuses participating in this NIH project. At UNC, the study is led by an interdisciplinary group of investigators whose expertise spans neuroimaging, endocrinology, pediatrics, occupational therapy and pediatric neuropsychology.

Read more

UNC School of Medicine Office of Research awards pilot funding to Moran and Kulis team for cutting-edge New Approach Methodologies research.

Read more

Joseph Muenzer, MD, PhD, leads research on groundbreaking therapy that offers hope for patients across the world living with a devastating genetic disorder. Ongoing clinical research at UNC could lead to a first-of-its-kind enzyme replacement therapy for Hunter syndrome, an ultra-rare disorder that causes progressive multisystem disease and neurologic decline.

Read more